KEY FEATURES
Full Name | Annexin A1 |
---|---|
Synonym | lipocortin I,ANX1,LPC1,Annexin I,Annexin-1,Calpactin II,Calpactin-2,Chromobindin-9,Lipocortin I,Phospholipase A2 inhibitory protein,p35 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.31-20ng/mL |
Sensitivity | 0.19ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human ANXA1 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ANXA1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ANXA1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ANXA1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ANXA1. You can calculate the concentration of Human ANXA1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ANXA1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 1 | 2.47 | 8.62 | 1 | 2.4 | 8.79 |
Standard deviation | 0.06 | 0.12 | 0.42 | 0.05 | 0.1 | 0.37 |
CV(%) | 5.75 | 4.72 | 4.82 | 5.15 | 4.12 | 4.16 |
RECOVERY
The recovery of Human ANXA1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 86-99 | 93 |
EDTA plasma (n=8) | 87-97 | 92 |
Cell culture media (n=8) | 93-105 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ANXA1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with ANXA1 ELISA Kits
FPR1 ELISA Kit | publications with ANXA1 and FPR1 |
S100A11 ELISA Kit | publications with ANXA1 and S100A11 |
SRC ELISA Kit | publications with ANXA1 and SRC |
EGFR ELISA Kit | publications with ANXA1 and EGFR |
TGM2 ELISA Kit | publications with ANXA1 and TGM2 |
Pathways associated with ANXA1 ELISA Kit
Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands Pathway | Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands Pathway |
G Alpha (i) Signalling Events Pathway | G Alpha (i) Signalling Events Pathway |
G Alpha (q) Signalling Events Pathway | G Alpha (q) Signalling Events Pathway |
GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
Gastrin-CREB Signalling Pathway Via PKC And MAPK | Gastrin-CREB Signalling Pathway Via PKC And MAPK |
Integrated Breast Cancer Pathway | Integrated Breast Cancer Pathway |
Integrated Pancreatic Cancer Pathway | Integrated Pancreatic Cancer Pathway |
Peptide Ligand-binding Receptors Pathway | Peptide Ligand-binding Receptors Pathway |
Diseases associated with ANXA1 ELISA Kit
Neoplasms | publications with ANXA1 and Neoplasms |
Inflammation | publications with ANXA1 and Inflammation |
Carcinoma | publications with ANXA1 and Carcinoma |
Neoplasm Metastasis | publications with ANXA1 and Neoplasm Metastasis |
Brain Diseases | publications with ANXA1 and Brain Diseases |
Carcinoma, Squamous Cell | publications with ANXA1 and Carcinoma, Squamous Cell |
Necrosis | publications with ANXA1 and Necrosis |
Pain | publications with ANXA1 and Pain |
Fibrosis | publications with ANXA1 and Fibrosis |
Lymphatic Metastasis | publications with ANXA1 and Lymphatic Metastasis |
Organs/Tissues associated with ANXA1 ELISA Kit
Blood | publications with ANXA1 and Blood |
Brain | publications with ANXA1 and Brain |
Vascular | publications with ANXA1 and Vascular |
Lung | publications with ANXA1 and Lung |
Pituitary Gland | publications with ANXA1 and Pituitary Gland |
Liver | publications with ANXA1 and Liver |
Lymph Node | publications with ANXA1 and Lymph Node |
Muscle | publications with ANXA1 and Muscle |
Bone | publications with ANXA1 and Bone |
Stomach | publications with ANXA1 and Stomach |